1. Home
  2. WGO vs ABUS Comparison

WGO vs ABUS Comparison

Compare WGO & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Winnebago Industries Inc.

WGO

Winnebago Industries Inc.

HOLD

Current Price

$31.81

Market Cap

929.1M

Sector

Industrials

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.33

Market Cap

929.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGO
ABUS
Founded
1958
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.1M
929.6M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
WGO
ABUS
Price
$31.81
$4.33
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$42.78
$5.00
AVG Volume (30 Days)
515.0K
1.9M
Earning Date
03-25-2026
05-14-2026
Dividend Yield
4.40%
N/A
EPS Growth
106.82
55.26
EPS
0.36
N/A
Revenue
$1,985,674,000.00
$14,083,000.00
Revenue This Year
$5.10
N/A
Revenue Next Year
$4.69
$239.71
P/E Ratio
$88.39
N/A
Revenue Growth
N/A
128.21
52 Week Low
$28.40
$3.04
52 Week High
$50.16
$5.10

Technical Indicators

Market Signals
Indicator
WGO
ABUS
Relative Strength Index (RSI) 44.84 48.45
Support Level $28.81 $4.17
Resistance Level $35.38 $4.64
Average True Range (ATR) 1.07 0.17
MACD 0.08 0.01
Stochastic Oscillator 38.95 50.81

Price Performance

Historical Comparison
WGO
ABUS

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was $2.8 billion in fiscal 2025. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 84% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total fiscal 2025 RV unit volume was 36,911. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: